ARTICLE | Distillery Therapeutics
Therapeutics: Interferon α/β receptor 1 (IFNAR1); tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
March 31, 2016 7:00 AM UTC
Cell culture and mouse studies suggest that combining inhibitors of IFNAR1 and TRAIL could help treat acute respiratory distress syndrome (ARDS) and other types of acute lung injury (ALI) caused by in...